1.4200
+0.1300
+(10.08%)
At close: February 18 at 9:50:04 PM GMT+1
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
| Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
|---|---|---|---|
| CALLICUTT JACK W Chief Financial Officer | Conversion of Exercise of derivative security | Dec 23, 2024 | 7,614 |
| CZIRR JAMES C Beneficial Owner of more than 10% of a Class of Security | Sale | Apr 23, 2024 | -- |
| ELDRED KARY N. Director | Purchase | Dec 24, 2024 | 68,107 |
| FREEMAN KEVIN D Director | Purchase | Dec 24, 2024 | 142,832 |
| JAMIL KHURRAM Officer | Conversion of Exercise of derivative security | Dec 23, 2024 | 26,346 |
| LEWIS JOEL Chief Executive Officer | Conversion of Exercise of derivative security | Dec 23, 2024 | 899,012 |
| SHLEVIN HAROLD H Director | Purchase | Dec 30, 2024 | 15,206 |
| UIHLEIN RICHARD E Director and Beneficial Owner of more than 10% of a Class of Security | Stock Award(Grant) | Jan 23, 2025 | 10,329,000 |
| ZORDANI RICHARD A. JR Director | Purchase | Dec 24, 2024 | 44,083 |
Related Tickers
CRO.DU hVIVO PLC
0.1920
0.00%
CRO.BE Open Orphan PLC
0.2120
0.00%
OPORF hVIVO plc
0.2400
-31.43%
6XY.F HBM Holdings Limited
0.5950
+10.19%
HPHA.F Heidelberg Pharma AG
2.2900
-0.87%
CRO.F hVIVO plc
0.1860
-19.83%
EU6.F PDS Biotechnology Corporation
1.4950
+0.47%
AYJ.DE Valneva SE
3.5520
+5.28%
J90.F NurExone Biologic Inc.
0.3920
0.00%
ALTME.PA TME Pharma N.V.
0.0755
-2.20%